... x-rays are used to treat cancer. 24ChemotherapyChemotherapy uses drugs to kill cancer cells. It may be given to women with Stage I, II, III, or IV breast cancer. Chemotherapy may be given ... lymph nodes. Stage IIIBe breast tumor can be any size, and it has grown into the chest wall or the skin of the breast. e breast may be swollen or the breast skin may have lumps.e cancer may ... problems that can result from cancer treatment ■ A new breast cancer Checkups usually include an exam of the neck, underarm, chest, and breast areas. Since a new breastcancer may develop, you...
... Pharmacopro-teomic analysis of prechemotherapy and postchemotherapyplasma samples from patients receiving neoadjuvant or adju-vant chemotherapy for breast carcinoma. Cancer 2004,100:1814-1822.40. ... in personalized therapy for breast cancer. Clin Cancer Res 2008, 14:8019-8026.53. Hayashi S, Yamaguchi Y: Estrogen signaling pathway and hor-monal therapy. BreastCancer 2008, 15:256-261.54. ... patterns specific for healthy persons and breastcancer patientsAt first we compared the serum proteome patterns of 104healthy women and 92 early stagebreastcancer patients.Spectral components...
... Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer 2004, 100:1814-1822.32. ... usuallyexceeds 80%). Primary therapy for breastcancer is usuallybased on surgery, either radical or breast- conservingmastectomy. However, even in early stagecancer somepatients are at high risk ... analysis in diagnostics of breast cancer. Theseworks identified serum (or plasma) proteome patternsspecific for patients with breastcancer at either early orlate clinical stages [19-29]. Different...
... overall, women with breast cancer fare well by 12 months following diagno-sis; however, interventions are needed to improve breast cancer- related concerns among all women with breast cancer and physical ... co-morbid-ities (other than breast cancer) , while non-urban breast cancer survivors were more likely to be sedentary and/or have two or more co-morbidities (other than breast cancer) , when compared ... well-being subscale. Women with breast cancer also completed 13 questions on breast cancer concerns and arm morbidity (FACT-B+4), with totalscores from 0-52 for the breastcancer concerns sub-scale,...
... first-line chemotherapy in this study seems to indicate that this strategy should be recommended in patients with an ER or PgR positive tumour. Key words: Breast cancer; maintenance treatment; chemotherapy; ... treated for metastatic breastcancer in 4 French cancer centres. The diagnosis of metastasis was made between 1992 and 2002. A total of 772 patients received first-line chemotherapy [4]. Because ... HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREASTCANCER Armelle Dufresne 1, Xavier Pivot 2, Christophe Tournigand3,...
... now considered a standard of care in early breast cancers withN0 axillae; however, its role in locally advanced breastcancer (LABC) after neo -adjuvant chemotherapy (NACT) isstill being debated. ... advanced breast cancers (LABC).The current treatment guidelines for LABC focus uponmultimodality approach i.e. neo-adjuvant chemotherapy(NACT)followedbysurgeryandadjuvanttherapiesinthe form of chemotherapy, ... the effects of adjuvant chemotherapy [4-7].More recently, the indications for NACT have also beenextended to selected patients with an early staged dis-ease to allow breast conserving surgery...
... carcinoma of the breast and 40,000 women die ofthe disease every year [2]. Although breastcancer is cur-rently the second most commo n cancer among Indianwomen (19%) after cervical cancer (30%), ... the urban cancer registries of Delhi and Mumbai it has rapidlyovertaken cervical cancer in frequency. In India majorityof breastcancer cases (30-50%) present at locallyadvanced stage [3] ... chemotherapy inlocally advanced breastcancer patients. Additional workis necessary to elucidate the specific mechanisms bywhich the androgens and AR influences breast cancer cells proliferation...
... therapy versus conventional postopera-tive whole -breast radiotherapy after breast- conservingsurgery for the management of early -stage invasive breast cancer (a trial update). Amer J Surg 2007, 194:507-510.19. ... IORT is needed to establish clinicalefficacy and safety for patients with early -stage breast cancer. BackgroundSeveral large randomized trials with extended follow-uphave shown that breast ... XB in the outpatient treatmentof early -stage breastcancer patients were recently pre-sented at the American Society of Clinical Oncology(ASCO) BreastCancer Symposium. Treatment with XBwas...
... the use of breast- conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001, 19:2254-2262.4. Arthur DW, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation ... study comparing breast- conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.6. Morrow M: Rational local therapy for breast cancer. N Engl J ... accelerated partial breast irradiation. BreastCancer 2008, 15:101-107.27. Powell SN: The radiobiology of accelerated partial breast irradiation. In Accelerated partial breast irradiation:...
... 193 69 53 59 Cancer site/stagingAll TonsilAll stage 4Oropharynx54% Stage4 60%Oropharynx53% Stage 4 81%Oropharynx35% Stage 4 83%Oropharynx 44% Stage 4 96%All Oropharynx Stage 4 65%Oropharynx62%tonguebase Stage ... performed stratified by tumour stag e(T stage) , nodal stage (N stage) and treatment (induc-tion chemotherapy followed by concurrent chemora-diotherapy or induction chemotherapy followed byradiotherapy ... docetaxel in unresectable head andneck cancer. N Engl J Med 2007, 357(17):1695-704.14. Cancer Research UK Cancer Statistics. [http://info.cancerresearchuk.org/cancerstats/types/oral/incidence/],...
... detect breast cancer. Clin Chem 2002;48(8): 1296–1304 27. Mathelin C. Cromer A, Wendling C, Tomasetto C, Rio MC: Serum biomarkers for detection of breast cancers: a prospective study. BreastCancer ... patients with pT1–2 breast cancer. Anticancer Res 2004; 24(5): 3221–3224. 11. Stein RC, Zvelebil MJ: The application of 2D gel-based prote-omics methods to the study of breast cancer. J Mammary ... studies is needed to consider of the efficacy of Bc1 and Bc2 in early diagnosis of the BC. Key words: BreastCancer diagnosis, Serum Biomarkers, Bc1, Bc2, and Bc3 INTRODUCTION Breast cancer (BC)...